Find uplifting stories about heroes, innovations, and solutions
46681 results for "time trial"
The FDA just announced a revolutionary approach that could cut years off the time it takes new treatments to reach patients. For the first time, regulators will monitor clinical trials as they happen, watching results unfold in real time instead of waiting months for reports.
Swiss cyclist Marlen Reusser dominated stage 4 of the Tour de France Femmes, claiming victory in a thrilling time trial that reshuffled the overall standings. The world champion now leads the race by just 14 seconds, setting up an exciting finish for women's cycling's biggest event.
The 2027 women's Tour de France will make history with its first-ever team time trial through London streets. Both men's and women's races will start in Britain for the first time, marking a breakthrough moment for women's cycling.
Australian cyclists Ben O'Connor, Jai Hindley, and Michael Storer are dominating the Giro d'Italia, claiming three spots in the top seven after a grueling time trial. The West Australian trio sits within 40 seconds of each other as they chase cycling's biggest prize.
Western Australia just became the first Australian state to trial free full-time kindergarten, giving working families at five schools a chance to save thousands in childcare costs. If successful, the $33.8 million program could transform early education access across the state.
The FDA just launched two groundbreaking clinical trials that send safety data to regulators instantly, cutting years from the drug approval process. For patients waiting on life-saving treatments, this could change everything.
A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial. Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.
A new FDA program will speed up early-stage clinical trials by up to a year, making life-saving treatments reach patients faster. The initiative aims to bring more medical research back to the United States.
A groundbreaking new drug nearly doubled survival time for people with advanced pancreatic cancer, marking the biggest treatment advance in over a decade. The success is sparking hope that other hard-to-treat cancers could soon follow.
Artificial intelligence is saving millions of dollars and weeks of time in cancer drug trials, according to groundbreaking research from Tufts University. The technology could help more lifesaving treatments reach patients faster.
The FDA just launched a pilot program to use artificial intelligence to make life-saving clinical trials faster and more efficient. Two major drug companies are already testing treatments in real time using the new system.
Vanderbilt's undergraduate mock trial team just punched their ticket to nationals for the first time in over a decade. The A Team went 7-1 in Memphis, proving student-run programs can compete with the best.
Annie Fields was diagnosed with aggressive cancer three times, including while 35 weeks pregnant. After pioneering treatments and trials, her latest scans show no trace of the disease once considered terminal.
A daily pill for advanced pancreatic cancer nearly doubled survival time in a major trial, offering new hope for one of the deadliest cancers. Patients lived a median of 13.2 months compared to 6.7 months with standard chemotherapy.
Clinical trials are getting faster thanks to artificial intelligence, but industry experts say strong relationships between researchers and trial sites remain the foundation of real progress. Better communication and collaboration could slash delays that happen before trials even begin.
A new treatment called daraxonrasib has shown remarkable results for advanced pancreatic cancer patients, nearly doubling their survival time in clinical trials. The breakthrough offers fresh hope for one of the deadliest forms of cancer.
A breakthrough drug for pancreatic cancer has doubled survival times in clinical trials, and ten hospitals across three states are now offering early access to eligible patients. The treatment targets specific genetic mutations found in over 90% of pancreatic cancers.
A groundbreaking pill targeting mutations in 90% of pancreatic cancer patients has approximately doubled survival time in clinical trials, offering new hope for one of medicine's toughest challenges. After decades of failed attempts, researchers have finally cracked a target once considered "undruggable."
A breakthrough treatment for aggressive endometrial cancer significantly extended survival in clinical trials, offering hope for patients who've run out of options. This marks the first time any drug of its kind has outperformed chemotherapy for this increasingly deadly cancer.
A new pill for ulcerative colitis helped half of patients achieve complete remission in a groundbreaking trial, five times better than placebo. The results represent the best success rate ever reported for an oral medication treating this painful inflammatory bowel disease.
Showing 20 of 46681